Versius Clinical Study in Robot Assisted Inguinal Hernia Repair Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorCMR Surgical Ltd

About this trial

The objective of this clinical trial is to evaluate the safety and efficacy of Versius in Inguinal Hernia repair surgery

Eligibility criteria

Qualifiers

Adult patients 22 years of age and older, deemed eligible for elective minimal invasive inguinal Hernia repair surgery.

Patients providing written informed consent to participate in the study.

Disqualifiers

Patient unwilling to provide informed consent.

Medical contraindication for general anaesthesia or minimally invasive procedure.

Patient participation in an interventional clinical study that could impact primary outcomes results.

Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above.

Trial design

Treatments tested in this trial

  • Versius Surgical System

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

CMR Surgical Ltd

Lead sponsor

Division of General Oncologic and Minimally Invasive Surgery, Niguarda Hospital Milan

Collaborator